John P. Sharp
Equibles does not estimate personal net worth.
Get an email with a short summary when Cadrenal Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CVKD alertsAbout John P. Sharp
John P. Sharp is recorded as CFO at Cadrenal Therapeutics, Inc. (CVKD) since June 25, 2026. The newest filing on record that lists John P. Sharp as CFO at Cadrenal Therapeutics, Inc. (CVKD) is dated August 3, 2026. Cadrenal Therapeutics, Inc. reported in an 8-K filed June 29, 2026 that John P. Sharp was appointed Interim Chief Financial Officer, effective June 25, 2026. Cadrenal Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cadrenal Therapeutics, Inc. includes Matthew K. Szot (CFO), Quang X. Pham (CFO, Chief Accounting Officer and Board Member), Jeffrey Cole (COO) and 7 others.
“On June 25, 2026, the Board of Directors (the "Board") of Cadrenal Therapeutics, Inc. (the "Company") appointed John P. Sharp as Interim Chief Financial Officer of the Company.”
Affiliation history
-
Current
2026-06-25–present
Last confirmed August 3, 2026
Company network
Leadership on record at Cadrenal Therapeutics, Inc.
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Jeffrey Cole COO
- Class I Directors Board Member
- Glynn Wilson Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Lee Scott Golden, M.D. Board Member
- Robert Lisicki Board Member
- Steven Zelenkofske Board Member